Cipher Pharmaceuticals Inc. (TSX:CPH) is looking for M&A. Craig Mull, Interim Chief Executive Officer said, "Turning briefly to M&A. Our strong balance sheet and credit facility with RBC puts us in an excellent position to source product and company acquisitions. As rising interest rates are leading many pharmaceutical companies to increasingly turn to asset divestitures, we resolved -- to resolve cash flow problems. We continue to evaluate a number of potential transactions in our M&A pipeline, and we look forward to reporting future developments in this area. With a strong development pipeline and available capital to actively pursue M&A, we are confident in our ability to accelerate growth and drive shareholder value.

I will now turn the call over to Bryan Jacobs for a discussion of our detailed financial results".